scholarly journals Alcohol Consumption and Survival after a Breast Cancer Diagnosis: A Literature-Based Meta-analysis and Collaborative Analysis of Data for 29,239 Cases

2014 ◽  
Vol 23 (6) ◽  
pp. 934-945 ◽  
Author(s):  
Alaa M.G. Ali ◽  
Marjanka K. Schmidt ◽  
Manjeet K. Bolla ◽  
Qin Wang ◽  
M. Gago-Dominguez ◽  
...  
2018 ◽  
Vol 18 (1) ◽  
pp. e79-e88 ◽  
Author(s):  
Brigitte Gerstl ◽  
Elizabeth Sullivan ◽  
Angela Ives ◽  
Christobel Saunders ◽  
Handan Wand ◽  
...  

Author(s):  
Justine Fortin ◽  
Mélissandre Leblanc ◽  
Guillaume Elgbeili ◽  
Matthew J. Cordova ◽  
Marie-France Marin ◽  
...  

2003 ◽  
Vol 80 (1) ◽  
pp. 115-126 ◽  
Author(s):  
Moishe Liberman ◽  
Fotini Sampalis ◽  
David S. Mulder ◽  
John S. Sampalis

2015 ◽  
Vol 107 (12) ◽  
pp. djv275 ◽  
Author(s):  
Mary C. Playdon ◽  
Michael B. Bracken ◽  
Tara B. Sanft ◽  
Jennifer A. Ligibel ◽  
Maura Harrigan ◽  
...  

2020 ◽  
Author(s):  
Chunchun SHAO ◽  
Zhi gang YU ◽  
Juan XIAO ◽  
Li yuan LIU ◽  
Fan zhen HONG ◽  
...  

Abstract Background Pregnancy-associated breast cancer (PABC) is defined as breast cancer that is diagnosed during pregnancy and/or the postpartum period. Definitions of the duration of the postpartum period have been controversial, and this variability may lead to diverse results regarding prognosis. Moreover, evidence on the dose-response association between the time from the last pregnancy to breast cancer diagnosis and overall mortality has not been synthesized. Methods We systematically searched PubMed, Embase, and the Cochrane Library for observational studies on the prognosis of PABC published up to June 1, 2019. We estimated summary-adjusted hazard ratios (HRs) and the corresponding 95% confidence intervals (CIs). Subgroup analyses based on diagnosis time, PABC definition, geographic region, year of publication and estimation procedure for HR were performed. Additionally, dose-response analysis was conducted by using the variance weighted least-squares regression (VWLS) trend estimation. Results A total of 54 articles (76 studies) were included in our study. PABC was associated with poor prognosis for overall survival (OS), disease-free survival (DFS) and cause-specific survival (CSS), and the pooled HRs with 95% CIs were 1.45 (1.30-1.63), 1.39 (1.25-1.54) and 1.40 (1.17-1.68), respectively. The corresponding reference category was non-PABC patients. According to subgroup analyses, the varied definition of PABC led to diverse results. The dose-response analysis indicated a nonlinear association between the time from the last delivery to breast cancer diagnosis and the HR of overall mortality (P<0.001). Compared to nulliparous women, the mortality was almost 60% higher in women with PABC diagnosed at 12 months after the last delivery (HR=1.59, 95% CI 1.30-1.82), and the mortality was not significantly different at 70 months after the last delivery (HR=1.14, 95% CI 0.99-1.25). This finding suggests that the definition of PABC should be extended to include patients diagnosed up to approximately six years postpartum (70 months after the last delivery) to capture the increased risk. Conclusion This meta-analysis suggests that PABC is associated with poor prognosis, and the definition of PABC should be extended to include patients diagnosed up to approximately six years postpartum.


2016 ◽  
Vol 36 (2-3) ◽  
pp. 77-89 ◽  
Author(s):  
Natasha Din ◽  
Isabel Elaine Allen ◽  
William A. Satariano ◽  
Joshua Demb ◽  
Dejana Braithwaite

Sign in / Sign up

Export Citation Format

Share Document